R13
Sign inGet started
🇬🇧

DEMURIS LIMITED

72.11 · Research and experimental development on biotechnologySIC72110LargeID06255507

📍 3 WEEKLEY WOOD CLOSE, KETTERING, NORTHAMPTONSHIRE, NN14 1UQ, UNITED KINGDOM

Financial data

Sign in to unlock
Revenue
•••••
EBIT
•••••
EBITDA
•••••
Net result
•••••
Total assets
•••••
Equity
•••••
Total debtors
•••••
Fiscal year
2024
Revenue, EBIT, net result and balance-sheet figures are as reported to the public register. EBITDA marked Estimated is derived from revenue × the sector-average margin (used where EBITDA is not publicly filed, e.g. France) and is not an audited figure.

Other companies in this sector

Same country and activity, ranked by how much data we hold. The list is free — open any company to see its own page.

CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITEDfinancials→CHARLES RIVER U.K. LIMITEDfinancials→THERADEX (EUROPE) LIMITEDfinancials→CONSTRUCTIVE BIOLOGY LIMITEDfinancials→MEDPHARM LIMITEDfinancials→OXFORD GENE TECHNOLOGY (OPERATIONS) LTDfinancials→

Ownership

1

Who owns this company. Register facts are shown exactly as recorded. We show recorded facts only — never an inferred owner type.

🏢
Corporate ownerShares 75-100%
Odyssey Therapeutics, Inc.
As recorded in the UK PSC register

Direction

13
Sign in to unlock
  • •••••••••••
    •••••
  • •••••••••••
    •••••
  • •••••••••••
    •••••
11 board members · 2 corporate officers · unlocks alongside financials

Beneficial owners

1PSC register · UK Companies Actunlocks alongside financials
•••••••••••
•••••

Source: Companies House PSC register

Data sourced from official commercial registries. Last updated when this company filed its accounts.

Discover more

More companies in Research and experimental →